BioAtla to Participate in the Jefferies Healthcare Conference
SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that the Company’s management will participate in a fireside chat and scheduled one-on-one investor meetings at the Jefferies Healthcare Conference, to be held in New York, NY June 7-9, 2023.
Format: Fireside chat and scheduled one-on-one investor meetings
About BioAtla, Inc.
SESSION DETAILS PENDING
The Connection Between Technology, Employee Experience, and Business Success